Sequencing Pancreatic Cancer
The Australian Pancreatic Genome Initiative (APGI) is working to map the genetic blueprint of pancreatic cancer.
|
IMPaCT Trial
Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer. Get Email Updates
Connect with us
  Familial Cancer Cohort
If you would like to be involved in the project please click here to find out more. |
Comments (0) |
